Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Arbutus Biopharma Corp

Arbutus Biopharma Corp

ABUS · NASDAQ
ABUS · NASDAQ

Next Earnings: 30 Apr 2025

3.28
USD-0.04-1.06%

Latest News

    @eWhispers
    eWhispers

    #earnings before the open tomorrow https://t.co/lObOE0dgsr $MRNA $PENN $VIAC $NKLA $GOLD $REGN $W $HIMX $LSPD $BLDR $DOCN $CI $VSTO $CYBR $LNG $PWR $RGS $PLNT $K $ERJ $FIS $DISH $PZZA $CARS $DNB $DUK $MBUU $CTXS $AHCO $VMC $GEO $EPAM $CHH $ABC $APD $BXRX $IRM $LITE $ABUS $SO https://t.co/fIMvfKVlk4

    Analysts Recommendations

    Bullish

    Buy

    Strong Buy

    Buy

    Hold

    Sell

    Strong Sell

    Day Range

    3.28USD
    3.34USD

    52 Week Range

    2.30USD
    4.72USD

    Market Cap

    627.22MUSD

    About

    General Information

    Type

    Common Stock

    Exchange

    NASDAQ

    Currency Code

    USD

    Currency Name

    US Dollar

    Country Name

    USA

    Country ISO

    US

    ISIN

    CA03879J1003

    CUSIP

    87911B209

    Sector

    Healthcare

    Industry

    Biotechnology

    Fiscal Year End

    December

    IPO date

    -

    Updated At

    -

    Highlights

    PE Ratio

    -

    PEG Ratio

    -

    Book Value

    0.56

    Dividend Share

    -

    Dividend Yield

    -

    Earnings Share

    -0.43

    Wall Street Target Price

    5.19

    EPS Estimate Current Year

    -0.55

    EPS Estimate Next Year

    -0.48

    EPS Estimate Current Quarter

    -0.09

    EPS Estimate Next Quarter

    -0.08

    Most Recent Quarter

    -

    Profitability

    Revenue TTM

    6,742,000

    Gross Profit TTM

    -56,049,000

    EBITDA

    -77,140,000

    Profit Margin

    0.00%

    Return On Assets TTM

    -32.83%

    Return On Equity TTM

    -67.81%

    Revenue Per Share TTM

    0.037

    Qtly Revenue Growth YOY

    -71.30%

    Diluted Eps TTM

    -0.43

    Qtly Earnings Growth YOY

    0.00%

    Valuation

    Trailing PE

    0.00

    Forward PE

    0

    Price Sales TTM

    93.0315

    Price Book MRQ

    5.8679

    Enterprise Value Revenue

    74

    Enterprise Value EBITDA

    -5

    Peers analysis

    • Alnylam Pharmaceuticals Inc
      ALNYAlnylam Pharmaceuticals Inc

      282.01

      11.07%
    • CSL Ltd
      CSLLYCSL Ltd

      80.47

      0.68%
    • argenx NV ADR
      ARGXargenx NV ADR

      615.02

      0.16%
    • CSL Limited
      CMXHFCSL Limited

      155.00

      0.00%
    • Be
      ONCBeiGene, Ltd.

      251.98

      -4.04%
    • UCB SA ADR
      UCBJYUCB SA ADR

      97.06

      -1.75%
    • Vertex Pharmaceuticals Inc
      VRTXVertex Pharmaceuticals Inc

      502.17

      -1.55%
    • UCB SA
      UCBJFUCB SA

      190.32

      -1.26%
    • BioNTech SE
      BNTXBioNTech SE

      95.38

      -0.83%
    • Regeneron Pharmaceuticals Inc
      REGNRegeneron Pharmaceuticals Inc

      658.48

      -0.59%
    XM

    Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

    Trade with a Trusted, Award-Winning Broker.

    Trading involves risk. The value of investments may go up or down. Trade responsibly.

    FAQs

    What is Arbutus Biopharma Corp stock price today?

    What is Arbutus Biopharma Corp stock ticker?

    Is ABUS stock price going up?

    What is the analyst recommendation for ABUS?

    What is ABUS market cap?

    Does ABUS release financial reports?

    When is ABUS next earnings date?

    What were ABUS Earnings for the last quarter?

    What was ABUS Revenue for the last quarter?

    What was ABUS Net Income for the last quarter?

    Does ABUS pay dividends?

    How many employees does ABUS have?

    What is ABUS EBITDA?

    How to buy ABUS stocks?

    Should I invest in ABUS stock?